|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||8.25 - 8.45|
|52 Week Range||4.72 - 8.45|
|PE Ratio (TTM)||88.71|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Clinuvel Pharmaceuticals Limited (ASX:CUV) is currently trading at a trailing P/E of 78.9x, which is higher than the industry average of 28x. While CUV might seem like a stock toRead More...
Clinuvel Pharmaceuticals Limited (ASX:CUV) delivered an ROE of 21.93% over the past 12 months, which is an impressive feat relative to its industry average of 17.87% during the same period.Read More...
MELBOURNE, Australia, Feb. 19, 2018-- CLINUVEL PHARMACEUTICALS LTD today released its new global Company positioning including the unveiling of a new Group identity and website. The global identity reflects ...